Former Humana CEO and founder dies

Amy Baxter | | Health Exec | Management

David Jones, former CEO of Humana and one of the founders of the health insurer, died Sept. 18, according to Courier Journal. He was 88, the outlet reported.

Jones served as CEO of Humana for 37 years and as board chairman for 44 years before he retired in 2007. When Jones helped launch the company, he reportedly borrowed $1,000 to get what was would become the nation’s largest nursing home chain off the ground. Since then, the organization became the world’s largest hospital company before transforming into a health insurance company worth $37 billion, Courier Journal noted.

Over Jones’ time at the helm, Humana rose in prominence and grew in size as the company evolved, with Jones being both “revered and feared,” the report said.

The current CEO of Humana is Bruce Broussard, who has held the position since 2013.

See the full story below:

Humana founder and Louisville business titan David Jones Sr. dies

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
Bipartisan bills in Congress would force insurance companies, PBMs to sell pharmacies
Anthem BCBS reverses course on anesthesia time limits
FDA issues Class I recall on insulin syringes due to risk of death
FDA issues Class I recall on insertion tubes after manufacturing error

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.